{
  "id": 16762948,
  "title": "Flop of new medication costs Novartis dearly",
  "url": "https://urgent.news/2026/10/27/flop-mit-neuem-medikament-kommt-novartis-teuer-zu-stehen",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-27T14:53:05.000Z",
  "source": {
    "name": "NZZ Wirtschaft",
    "slug": "nzz-wirtschaft",
    "url": "https://www.nzz.ch/wirtschaft/flop-mit-neuem-medikament-kommt-novartis-teuer-zu-stehen-ld.10045872"
  },
  "original_language": "de",
  "account": null,
  "summary": "The pharmaceutical company has to write off almost two billion dollars because a potential new drug did not show the desired effect. The company's CEO is downplaying the failure. However, many market observers are skeptical.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}